Basic Information
BioAI Health has developed an innovative, cost-effective platform that enables biopharmaceutical companies to leverage pathology, clinical, and genomic data for in-depth insights into how their drugs work and which patients they serve. The result is faster development, smaller trials, and improved efficacy and outcomes. To date, the company has grown and validated its capabilities and business through partnerships with the world’s five largest biopharmaceutical companies, as well as research and data collaborations with leading laboratories and universities in the U.S.
Bio-AI Health Inc.
United States of America
less than 15 people
January 01, 2020
--
info@bioaihealth.com

